Jack Higgins, Chief Scientific Officer at Immunome Inc. (IMNM), sold 22,000 shares at $25.32 ($334K) on 2026-09-11, disclosed to the SEC on 2026-09-15.
Scheduled sale ($334k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 8,800 | $0 | 0.0% |
| 2 | $25.32 | 13,200 | $334K | 100.0% |
| Total | $15.19 avg | 22,000 | $334K | 100% |
| Filing → |